首页 › 基金 › Commodore Capital LP › KYMR
Commodore Capital LP 对 KYMR 的持仓历史
KYMERA THERAPEUTICS INC · 医疗保健
Commodore Capital LP 在 Q2 2026 的 13F 申报中披露持有 KYMR(KYMERA THERAPEUTICS INC)250,000 股,市值约 US$28.7M,约占其申报组合的 1.71%,在其申报持仓中市值排名第 18 位。 Commodore Capital LP 最近 5 个申报季度中有 5 个季度披露了 KYMR 持仓,最早可追溯至 Q2 2025。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Commodore Capital LP 对 KYMR 的持仓演变
Commodore Capital LP 于 Q2 2025 首次披露 KYMR 持仓:750,000 股(约 US$32.7M)。 该持仓在 Q1 2026 达到峰值 750,000 股,市值约 US$62.5M。 在 5 次申报中,Commodore Capital LP 0 次增持、1 次减持、3 次保持不变。 最近一期申报(Q2 2026)显示持股 250,000 股、市值约 US$28.7M,环比减持 -500,000 股。。 持仓曾出现大幅变动:Q2 2026 减持约 67% (随后一个季度股价下跌 3%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2025 | 750.00K | $32.73M | 新进 |
| Q3 2025 | 750.00K | $42.45M | 持有 |
| Q4 2025 | 750.00K | $58.36M | 持有 |
| Q1 2026 | 750.00K | $62.47M | 持有 |
| Q2 2026 | 250.00K | $28.67M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 KYMR 与 13F 数据
KYMR(KYMERA THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 57 只申报持有 KYMR,申报仓位最大的包括:BAKER BROS. ADVISORS LP (US$992.7M), Avoro Capital Advisors LLC (US$857.1M), T. Rowe Price Investment Management, Inc. (US$717.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 KYMR 的基金
- BAKER BROS. ADVISORS LP 8.66M 股 · $992.73M · Q2 2026
- Avoro Capital Advisors LLC 7.47M 股 · $857.13M · Q2 2026
- T. Rowe Price Investment Management, Inc. 6.26M 股 · $717.52M · Q2 2026
- BVF INC/IL 3.87M 股 · $444.01M · Q2 2026
- Siren, L.L.C. 2.94M 股 · $336.65M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 2.85M 股 · $326.53M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 919.23K 股 · $105.41M · Q2 2026
- Merck & Co., Inc. 772.16K 股 · $88.54M · Q2 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 740.87K 股 · $84.96M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 504.21K 股 · $57.81M · Q2 2026
- Rock Springs Capital Management LP 453.16K 股 · $51.96M · Q2 2026
- Boxer Capital Management, LLC 429.10K 股 · $49.20M · Q2 2026
更多关于 Commodore Capital LP
常见问题
How long has Commodore Capital LP held KYMR?
Commodore Capital LP has disclosed KYMR holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is Commodore Capital LP's current position in KYMR?
As of Q2 2026, Commodore Capital LP holds 250.00K shares of KYMR (KYMERA THERAPEUTICS INC), valued at $28.67M, representing 1.71% of its reported portfolio and ranking #18.
Has Commodore Capital LP been buying or selling KYMR?
In the latest 13F filing (Q2 2026), Commodore Capital LP reduced its position in KYMR. The position peaked in Q1 2026 at 750.00K shares.
Which other funds hold KYMR?
Other major institutional holders of KYMR include BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, T. Rowe Price Investment Management, Inc., among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.